Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer

Adoptive cell therapy (ACT) is one of promising immunotherapies for cancer patients by providing a large amount of cancer antigen-specific effector T cells that can be manufactured rapidly by ex vivo gene engineering. To provide antigen-specificity to patients’ autologous T cells in a short-term cul...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuzaki, Junko, Lele, Shashikant, Odunsi, Kunle, Tsuji, Takemasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741298/
https://www.ncbi.nlm.nih.gov/pubmed/35003898
http://dx.doi.org/10.1080/2162402X.2021.2020983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741298/
https://www.ncbi.nlm.nih.gov/pubmed/35003898
http://dx.doi.org/10.1080/2162402X.2021.2020983

Ejemplares similares